EUVIMEDEUVIMED entdecken
Crossref

IN SILICO EVALUATION OF CURCUMIN AGAINST BRCA1 IN BREAST CANCER ADME PREDICTION AND MOLECULAR DOCKING STUDY

Peduru sukrutha reddy

Journal of Modern and Versatile Research Approach · 2026-11 · 4 (11)

DOI: 10.56975/jmvra.v4i11.200048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Modern and Versatile Research Approach, 2026-11. Verfasst von Peduru sukrutha reddy.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is one of the common cancers in women across the world and changes in the BRCA1 gene are a big part of how it starts. Curcumin is a substance found in turmeric and has been shown to have cancer fighting, inflammation reducing and cell protection abilities. In this study the qualities of curcumin as a drug and its ability to attach to the BRCA1 protein were looked at using computer-based methods. The way curcumin moves through the body and its qualities as a drug were estimated using SwissADME. It was tested against BRCA1 (PDB ID: 1JNX) using the CB-Dock2 server. Curcumin had a weight of 368.38 g/mol, a TPSA of 93.06 Ų and a WLOGP of 3.29 with no issues with Lipinski's rule of five. It was able to be absorbed in the gut, did not pass through the blood-brain barrier, was not a substrate for P-glycoprotein and had a bioavailability score of 0.55. Computer modeling showed the best way curcumin attached to BRCA1 with a Vina score of -6.2 kcal/mol in a space called C1 with a size of 225 ų and a center at (19, 69, 27). The findings suggest that curcumin has qualities like a drug and can stick well to BRCA1. It might be a start for developing treatments for breast cancer. More tests in the lab and in living organisms are needed to check if it works well.

Zitieren

APA

reddy, P. S. (2026). IN SILICO EVALUATION OF CURCUMIN AGAINST BRCA1 IN BREAST CANCER ADME PREDICTION AND MOLECULAR DOCKING STUDY. Journal of Modern and Versatile Research Approach, 4(11). https://doi.org/10.56975/jmvra.v4i11.200048

Vancouver

reddy PS. IN SILICO EVALUATION OF CURCUMIN AGAINST BRCA1 IN BREAST CANCER ADME PREDICTION AND MOLECULAR DOCKING STUDY. Journal of Modern and Versatile Research Approach. 2026;4(11). doi:10.56975/jmvra.v4i11.200048

BibTeX
@article{reddy2026,
  author = {reddy, Peduru sukrutha},
  title = {IN SILICO EVALUATION OF CURCUMIN AGAINST BRCA1 IN BREAST CANCER ADME PREDICTION AND MOLECULAR DOCKING STUDY},
  journal = {Journal of Modern and Versatile Research Approach},
  year = {2026},
  volume = {4},
  number = {11},
  doi = {10.56975/jmvra.v4i11.200048}
}
Kostenlos starten →